Filing Details

Accession Number:
0000919574-15-008478
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-30 17:23:50
Reporting Period:
2015-11-25
Filing Date:
2015-11-30
Accepted Time:
2015-11-30 17:23:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1157601 Synta Pharmaceuticals Corp SNTA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1325713 Bruce Kovner C/O Caxton Corporation
731 Alexander Road, Bldg. 2
Princeton NJ 08540
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-25 959,149 $0.49 3,489,499 No 4 S Indirect By OB Select Opportunities, LLC
Common Stock Disposition 2015-11-25 544,571 $0.49 1,981,218 No 4 S Indirect By Kovner 2012 Family Trust B
Common Stock Disposition 2015-11-27 596,132 $0.50 2,893,367 No 4 S Indirect By OB Select Opportunities, LLC
Common Stock Disposition 2015-11-27 338,463 $0.50 1,642,755 No 4 S Indirect By Kovner 2012 Family Trust B
Common Stock Disposition 2015-11-30 408,546 $0.43 2,484,821 No 4 S Indirect By OB Select Opportunities, LLC
Common Stock Disposition 2015-11-30 231,959 $0.43 1,410,796 No 4 S Indirect By Kovner 2012 Family Trust B
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By OB Select Opportunities, LLC
No 4 S Indirect By Kovner 2012 Family Trust B
No 4 S Indirect By OB Select Opportunities, LLC
No 4 S Indirect By Kovner 2012 Family Trust B
No 4 S Indirect By OB Select Opportunities, LLC
No 4 S Indirect By Kovner 2012 Family Trust B
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,092,677 Direct
Common Stock 2,279,146 Indirect By Wife
Common Stock 11,399,464 Indirect By KFO Holdings LLC
Common Stock 4,000,000 Indirect By Kovner 2015-A Investment Trust
Footnotes
  1. This constitutes the weighted average sale price. The prices range from $0.44 to $0.5118. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. This constitutes the weighted average sale price. The prices range from $0.4435 to $0.5005. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. This constitutes the weighted average sale price. The prices range from $0.428 to $0.463. The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. These shares are owned directly by OB Select Opportunities, LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of OB Select Opportunities, LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  5. These securities are owned by the wife of the Reporting Person and her estate planning vehicles.
  6. These shares are owned directly by KFO Holdings LLC and indirectly by the Reporting Person as chairman and sole shareholder of Caxton Corporation, the manager of KFO Holdings LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.